The use of inhaled ciclesonide in hospitalized patients with COVID-19 infection reduced in-hospital mortality and the likelihood of receiving invasive mechanical ventilation in those with severe COVID-19 infection. Further well-designed randomized control trials are indicated to validate our findings.
Availability of data and materials
Ethics approval and consent to participate
Approved by the Institutional Review Board of MacKay Memorial Hospital (approval no. 21MMHIS330e) and the need for written informed consent was waived. This study was performed in accordance with the Declaration of Helsinki.
Consent for publication
BMC Pulm Med. 2022;22(368) © 2022 BioMed Central, Ltd.